Vicente LLP Federal and International Cannabis and Psychedelics Law and Policy Update: November 2023
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
Nov 10, 2023
Federal and international law and policy insights, news and events from Vicente LLP.
By Shawn Hauser
Aug 31, 2023
The federal government formally acknowledged the medical use and low potential of abuse for cannabis, with the US Department of Health and Human Services recommending that cannabis be rescheduled to Schedule III under the Controlled Substances Act. While placement in Schedule III still criminalizes commercial cannabis activity at the federal level, it is a significant step on the path to ending prohibition. This rescheduling would eliminate the application of 280E tax penalties, reduce the level of criminal liability for cannabis-related activity, reduce barriers to research, legitimize the industry through gaining credibility and engagement by physicians and the medical community, and support a growing industry for the American economy.
Jul 12, 2023
Mushrooms are having a moment! Watch this session to learn about current and future business opportunities in the growing world of adaptogenic and functional mushrooms.
By Charles Alovisetti, Sahar Ayinehsazian
Mar 3, 2023
Given the wide variety of available functional/adaptogenic mushroom product forms, producers and consumers should be aware of the significant differences in regulations for food, food additives, and dietary supplements.
By Catie Wightman
Feb 13, 2023
In recent years, several CBD companies faced product liability lawsuits brought by consumers. Many of these cases were dismissed without prejudice or stayed until the FDA takes action to regulate CBD products. Now that the FDA said it will not take action to regulate CBD, could these cases be revived?
Feb 9, 2023
The FDA decided not to regulate CBD, denied three citizen petitions requesting CBD rulemaking or other FDA action, and announced it is now up to Congress to step in. Watch this webinar and learn what this means for your hemp-derived cannabinoids business.
By Andrea Golan
Jan 6, 2023
Minnesota hemp companies are being sued by the Minnesota Board of Pharmacy for selling high-THC hemp-derived edibles that allegedly contained 100 milligrams of hemp-derived THC per gummy bear and were intentionally marketed in a manner that is appealing to children. What standards may lower consumer safety risks for these products?
Jan 6, 2023
Florida state health regulators are looking to issue up to 22 more medical marijuana licenses to operators around the state. Sally Peebles dives into what this means for Medical Marijuana Treatment Center applicants in the Sunshine State.
By Catie Wightman, Michelle Bodian
Nov 30, 2022
On November 21, 2022, the FDA issued five warning letters to companies selling CBD, Delta-8, and other hemp products for humans and pets.
By Shane Pennington
Nov 9, 2022
What outcomes are possible from the impending administrative process to reconsider cannabis’s schedule I status? What are the implications of those various possible outcomes? And how should we all proceed in light of it all?
By Shane Pennington
Oct 21, 2022
To appreciate the gravity of the President’s scheduling directive and what could happen next, you need to understand (1) how the administrative process the President has set in motion will actually work and (2) how the agencies in charge have used it to affirm and reaffirm cannabis’s schedule I1 status repeatedly throughout the Comprehensive Drug Abuse Prevention and Control Act of 1970’s (“CSA”) history. Those topics are covered in this article.
By Shane Pennington
Oct 21, 2022
President Biden’s scheduling directive is enormously important. In fact, if permitted to run its course, it could revolutionize federal drug control law to a far greater degree than any of the many pending cannabis legalization bills.
Oct 17, 2022
Reserve your seat for Dutchie and Vicente Sederberg LLP’s co-hosted webinar about insurance and cannabis businesses on October 20!
Sep 27, 2022
Sally Kent Peebles will be in Jackson, Mississippi on October 7 to speak about cannabis business licensing at the Lucky Leaf Expo!
Aug 19, 2022
VS is pleased to announce that 14 attorneys from national cannabis law firm Vicente Sederberg LLP (VS) were recognized this week by Best Lawyers, the oldest and most respected peer-review publication in the legal profession.
By Catie Wightman, Ariane Beckman
Aug 11, 2022
The FDA is cracking down on companies making unlawful drug or disease claims about their products relating to CBD by recently issuing several warning letters to address these compliance violations.
Aug 1, 2022
Join VS, Dutchie, Mississippi Medical Marijuana Association (3MA) and Cure8 on August 18 for a cannabis business networking event in Jackson, Mississippi.
Jul 28, 2022
Update on hemp-related legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
By Sally Kent Peebles
Jul 20, 2022
The wait may soon be over for those wishing to enter the Florida medical marijuana market with the upcoming general application process opening for medical marijuana treatment centers.
May 20, 2022
On Friday, June 3 at 10 a.m. ET, Sally will join the panel "Legislative Updates: A Comparison of State Models."
May 17, 2022
Watch this VS live session for a timely discussion exploring intoxicating hemp-derived products.
By Michelle Bodian, Shawn Hauser, Catie Wightman
May 5, 2022
For the first time ever, the FDA issued warning letters to companies selling products containing hemp-derived Delta-8 THC. Notably, this is the first time the FDA has specifically enforced against Delta-8 products. Read this for key takeaways from these warning letters.
Apr 4, 2022
Update on hemp-related legislation and rulemaking, regulatory changes, and other noteworthy hemp news and events.
By Michelle Bodian, Jace Pohlman
Mar 30, 2022
The FDA and FTC are working together to target fraudulent COVID-19 claims made by CBD companies. Seven CBD product companies received warning letters. Read this article for a look into what to do—or not do—to avoid a warning.
Dec 20, 2021
While at MJBizCon, VS partner Sally Kent Peebles sat down with Haze Radio Network's "The Business of Cannabis." Have a listen!
Dec 4, 2021
VS attorney Sahar Ayinehsazian is slated to speak at the National Asian Pacific American Bar Association (NAPABA) Convention on December 10, 2021.
Oct 5, 2021
We look forward to seeing our colleagues, clients, and friends at MJBizCon in Las Vegas, October 19-22!
Aug 25, 2021
Vote for the panel "Sue 'n the DEA: Breaking the 50-Year NIDA Monopoly," featuring Shane Pennington to be included in SXSW 2022!
Aug 25, 2021
Vote for the panel "Sue 'n the DEA: Breaking the 50-Year NIDA Monopoly," featuring Shane Pennington to be included in SXSW 2022!
By Shawn Hauser
Aug 25, 2021
Recent NDIN notification objections from the FDA give us more insight into the agency's factors differentiating "full spectrum" hemp from CBD.
Aug 11, 2021
With a new Administration and Congress, changes in personnel at FDA, and new safety data being published, is 2021 the year when CBD will come out from under the FDA shadows to be legally marketed in all 50 states?
By Shawn Hauser
Jul 22, 2021
In this article, we’ll look at the history of CBD regulation in the United States, the trends that are dominating CBD regulation in 2021, and some of the state-specific regulations in the largest states.
Jun 3, 2021
The Florida Supreme Court recently issued a long-awaited ruling in the case Florida Department of Health v. Florigrown, LLC. VS partner Sally Kent Peebles recently discussed this and more with WJCT Public Media.
Apr 21, 2021
VS partner Sally Kent Peebles discusses her work in cannabis law and advocacy, including the founding of WISE Florida, on two episodes of the Canna Guys podcast.
Apr 19, 2021
VS attorney Sally Kent Peebles will participate in the panel "The Growing Field of Medical Marijuana - Mississippi and Beyond" on May 6, 2021.
Mar 29, 2021
VS partner Sally Kent Peebles was tapped to discuss Florida's medical cannabis law, specifically about medical marijuana use and employment.
Mar 29, 2021
Vicente Sederberg is monitoring local, state, and federal responses to the coronavirus (COVID-19) and how they may impact cannabis businesses, service providers, and consumers.
Mar 25, 2021
WISE Florida, a statewide education and advocacy initiative aimed at building support for legalizing and regulating cannabis for adult use, was launched on March 25, 2021.
Mar 17, 2021
As the number of medical marijuana patients in Florida continues to grow, some Florida state lawmakers are exploring a possible cap on the level of THC in medical marijuana products. VS partner Sally Kent Peebles recently discussed this with WJCT Public Media.
Feb 10, 2021
VS partner Sally Kent Peebles will discuss adult-use cannabis legalization in Florida with a Florida State Senator and State Representative.
By Charles Alovisetti, Sally Kent Peebles
Jan 15, 2021
As more law firms are fielding client questions about cannabis industry transactions, it can be challenging for corporate counsel to identify when they need cannabis regulatory counsel.
By Vicente Sederberg LLP
Dec 18, 2020
Vicente Sederberg attorneys wrote the book on cannabis law — and now you can own it! This comprehensive primer on all things cannabis law is a must-have for anyone seeking to understand the major practical legal issues facing the marijuana and hemp industries.
By Vicente Sederberg LLP
Dec 1, 2020
For our 10th anniversary, we take a look back at VS's history of leadership in cannabis law, the marijuana and hemp industries, and drug policy reform.
Oct 12, 2020
VS partner Sally Kent Peebles was elected co-chair of the Florida Department of Agriculture and Consumer Services Medical Cannabis Advisory Committee.
Sep 21, 2020
Four years after Florida voters approved the legalization of medical marijuana, edibles have been approved. VS Jacksonville attorney Sally Kent Peebles weighed in on this and other Florida cannabis issues with WJCT Public Media.
By Corey Cox
May 28, 2020
The CBD-based medicine, Epidiolex, was descheduled by the DEA and is no longer a controlled substance. What are the implications of this change and what, if anything, does it mean for CBD products in general?
By Charles Alovisetti, Elliot Choi, Sahar Ayinehsazian, Corey Cox
May 5, 2020
The continuing growth of the cannabis and hemp industries has given rise to the need for specifically tailored due diligence.
By Sally Kent Peebles, Caitlin Wightman
Apr 30, 2020
The hemp industry has arrived in Florida! After much anticipation, Florida farmers and hemp enthusiasts will finally be able to grow hemp right here in the Sunshine State.
Apr 23, 2020
The prestigious international legal directory once again gave VS a Nationwide Band 1 ranking, and this time around it also individually ranked three of the firm's partners.
Apr 17, 2020
Vicente Sederberg is monitoring the potential impact of the coronavirus (COVID-19) on hemp businesses, service providers, and consumers.
By Sally Kent Peebles
Apr 1, 2020
Vicente Sederberg is monitoring the potential impact of the coronavirus (COVID-19) on cannabis businesses, service providers, and consumers in Florida.
Mar 16, 2020
VS is open for business and communicating with regulators to help answer your questions.
Mar 2, 2020
Florida Department of Agriculture & Consumer Services are informing stakeholders on the intricacies of Florida hemp labeling requirements via webinars.
Nov 20, 2019
VS attorney Sally Kent Peebles was voted Chair of the Legislative & Legal subcommittee within the Florida Department of Agriculture and Consumer Services' Medical Cannabis Advisory Committee.
Aug 16, 2019
Tweets, calls and emails flooded the WLRN Florida Public Radio studio when VS Jacksonville attorney and Florida Medical Cannabis Advisory Committee member Sally Kent Peebles discussed cannabis and Florida politics on "The Florida Roundup."
Jul 18, 2019
VS attorney Sally Kent Peebles will participate in a cannabis industry retail real estate panel discussion at an ICSC event on July 25, 2019.
By Sally Kent Peebles, Partner
Jul 17, 2019
Florida First District Court of Appeal issued an important opinion on the Dept of Health vs Florigrown lawsuit, which opens the door to the possibility of the Florida market opening up to more cannabis businesses, with lower barriers to entry.